Design of Novel Chimeric Melanotropin−Deltorphin Analogues. Discovery of the First Potent Human Melanocortin 1 Receptor Antagonist-Reference-Cited by-同舟云学术

Design of Novel Chimeric Melanotropin−Deltorphin Analogues. Discovery of the First Potent Human Melanocortin 1 Receptor Antagonist

Published:2003-01-30 Issue:5 Volume:46 Page:810-819
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Han G.¹,Quillan J. M.¹,Carlson K.¹,Sadée W.¹,Hruby V. J.¹

Affiliation:

1. Department of Chemistry, University of Arizona, Tucson, Arizona 85721

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm020355o

Reference79 articles.

1. Cone, R. D.; Lu, D. S.; Koppula, S.; Vage, D. I.; Klungland, H.; Boston, B.; Chen, W. B.; Orth, D. N.; Pouton, C.; Kesterson, R. A. The Melanocortin Receptors: Agonists, Antagonists, and the Hormonal Control of Pigmentation.Recent Progress in Hormone Research; Endocrine Soc: Bethesda, 1996; Vol.51, pp 287−318.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2′)-Orn-NH₂] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2′)-Arg-NH₂];Journal of Medicinal Chemistry;2023-06-12

2. Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2017-10

3. The design of multitarget ligands for chronic and neuropathic pain;Future Medicinal Chemistry;2015-12

4. Peptide Design Strategies for G-Protein Coupled Receptors (GPCR);Peptide Chemistry and Drug Design;2015-02-13

5. Approaches to the rational design of selective melanocortin receptor antagonists;Expert Opinion on Drug Discovery;2011-03-24